rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-9-9
|
pubmed:abstractText |
Prostate cancer (PCa) patients with pretreatment prostate-specific antigen (PSA) >20 ng/ml have a high risk of biochemical and clinical failure and even cancer-related death after local therapy. Pretreatment predictors of outcome after radical prostatectomy (RP) in this patient group are necessary.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1873-7560
|
pubmed:author |
pubmed-author:BaderPiaP,
pubmed-author:FieuwsSteffenS,
pubmed-author:FrohnebergDetlefD,
pubmed-author:GonteroPaoloP,
pubmed-author:HsuChao-YuCY,
pubmed-author:JoniauStevenS,
pubmed-author:KneitzBurkhardB,
pubmed-author:MarchioroGiansilvioG,
pubmed-author:SpahnMartinM,
pubmed-author:TizzaniAlessandroA,
pubmed-author:TombalBertrandB,
pubmed-author:Van Der EecktKatieK,
pubmed-author:Van PoppelHeinH
|
pubmed:copyrightInfo |
Copyright 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-7; discussion 10-1
|
pubmed:meshHeading |
pubmed-meshheading:20299147-Aged,
pubmed-meshheading:20299147-Carcinoma,
pubmed-meshheading:20299147-Cohort Studies,
pubmed-meshheading:20299147-Europe,
pubmed-meshheading:20299147-Follow-Up Studies,
pubmed-meshheading:20299147-Humans,
pubmed-meshheading:20299147-Lymph Node Excision,
pubmed-meshheading:20299147-Male,
pubmed-meshheading:20299147-Middle Aged,
pubmed-meshheading:20299147-Neoplasm Recurrence, Local,
pubmed-meshheading:20299147-Neoplasm Staging,
pubmed-meshheading:20299147-Prognosis,
pubmed-meshheading:20299147-Prostate,
pubmed-meshheading:20299147-Prostate-Specific Antigen,
pubmed-meshheading:20299147-Prostatectomy,
pubmed-meshheading:20299147-Prostatic Neoplasms,
pubmed-meshheading:20299147-Retrospective Studies,
pubmed-meshheading:20299147-Risk Factors,
pubmed-meshheading:20299147-Treatment Outcome
|
pubmed:year |
2010
|
pubmed:articleTitle |
Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients.
|
pubmed:affiliation |
University Hospital Würzburg, Department of Urology and Pediatric Urology, Germany. Spahn_M@klinik.uni-wuerzburg.de
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|